Compuware Acquires XaTester and Partners with Parasoft to Deliver Essential Automated Unit Testing to Mainframe DevOps Teams
Topaz Further Established as the Leading Solution for Continuously Improving Velocity, Quality and Efficiency of Enterprise Systems
- Large enterprises must rigorously safeguard the quality of their mission-critical mainframe systems as digital demands drive them to develop and deploy mainframe code more quickly and frequently.
- With the acquisition of XaTester, new enhancements, and partnership with Parasoft, Compuware Topaz for Total Test is the clear leader in the automated unit testing essential for Agile and DevOps on the mainframe.
- With Topaz, developers at all skill levels can quickly and efficiently produce the highest-quality code for the mainframe-enabling enterprises to achieve the digital agility essential for success in fast-moving markets.
DETROIT, July 18, 2018 (GLOBE NEWSWIRE) -- Compuware today announced a product acquisition, enhancements to Topaz for Total Test, and a partnership that together dramatically improve the ability of large enterprises to embrace Agile and DevOps on their mainframes through the broader use of simplified, automated unit testing-which is essential for fast, safe and efficient development and deployment of new digital deliverables.
To deliver on its vision of Topaz for Total Test as the de facto standard for automating mainframe unit testing across all major mainframe environments and programming languages, Compuware has:
Acquired XaTester from Xact Consulting A/S, enabling developers to quickly create unit tests for both batch and CICS-based programs written in COBOL, PL/I and Assembler. CICS is especially important as the transaction processing technology of choice for many of the world's largest enterprises-especially financial institutions and insurance companies-due to its extremely high integrity, performance and scalability.
Enhanced Topaz for Total Test to provide automated unit testing for IMS batch and transactional applications. Testing for IMS is especially important given that contemporary developers often have little or no hands-on experience with IMS code. These enhancements complement Topaz for Total Test's existing support for batch applications written in COBOL-as well as its integration with leading cross-platform DevOps tools such as Jenkins, SonarSource SonarQube and Compuware ISPW.
- Partnered with Parasoft, a leading innovator in end-to-end test automation for software development. The first deliverable for the partnership is integration between Parasoft SOAtest and Topaz for Total Test. This integration enables developers working on mainframe applications to quickly and easily test API calls between mainframe and non-mainframe systems.
Topaz for Total Test fundamentally transforms mainframe development by giving developers the same type of unit testing capabilities on the mainframe they've become accustomed to on other platforms. Unit testing is a fundamental requirement for modern software development. It enables developers to find potential problems in their code as early as possible, to more quickly and frequently deliver incremental changes in software functionality, and to more granularly document code for the benefit of other developers.
The result for large enterprises is a unified DevOps toolchain that accelerates development across all platforms-including the mainframe-so they can more effectively compete in today's rapidly-changing markets.
"XaTester and Topaz for Total Test are two great and complementary products for automating mainframe unit testing, which is essential to DevOps," said Steen Brahe, Senior Product Manager, Compuware (formerly from Xact Consulting). "The unified tool will leverage the best from both products and fundamentally change how customers create, execute and automate unit and integration tests for mainframe applications."
"The XaTester unit testing software has proven its value. I am pleased that Compuware will work to blend its capabilities with Topaz for Total Test as it will benefit all mainframe customers," said Elvin Høyer, CEO at Xact Consulting.
"The new rules of the digital economy are putting pressure on our customers to achieve the utmost speed with the utmost quality," said Luke Tuddenham, Vice President at CPT, a global IT consulting services firm with a significant testing practice. "With today's announcements, Compuware has again demonstrated its leadership in innovative automated testing technologies for the mainframe that will help us help our clients to achieve this critical goal."
Compuware Topaz, a comprehensive suite of solutions, provides DevOps professionals at all skill levels with a visually intuitive environment where they can effectively understand and work on any mainframe application-regardless of age, complexity or lack of documentation. This simplified, streamlined approach is especially important as responsibility for applications running on the platform shifts from IT professionals with decades of mainframe-specific experience to a new generation of DevOps artisans who are more familiar with mainstream technologies such as Java and C++.
"REST and SOAP APIs provide the backbone of today's business-critical applications, especially when these services are used to access the power of the mainframe." said Parasoft VP of Products, Mark Lambert. "Test automation at the API layer is essential to delivering high quality at the speed of Agile and the Parasoft SOAtest plugin for Topaz brings API test automation directly to the mainframe developer, helping ensure the delivery of reliable, scalable and secure services."
Today's announcement comes during the 15th consecutive quarter that Compuware has delivered significant innovations that help large enterprises mainstream the mainframe, so they can better leverage the platform's unmatched performance, scalability, reliability, efficiency and security.
"Large enterprises increasingly recognize that digital innovation in the cloud must be paired with digital innovation on the mainframe," said Chris O'Malley, CEO of Compuware. "Compuware's passion and support for this mainframe-based digital innovation is unmatched-as we have once again demonstrated with this latest round of aggressive deliverables that enable Agile and DevOps best practices on the platform."
Compuware empowers the world's largest companies to excel in the digital economy by fully leveraging their high-value mainframe investments. We do this by delivering highly innovative solutions that uniquely enable IT professionals with mainstream skills to manage mainframe applications, data, and platform operations. Learn more at compuware.com.
Follow us on:
For Sales and Marketing Information
Compuware Corporation, One Campus Martius, Detroit MI 48226, 800-266-7892, www.compuware.com.
Copyright © 2018, Compuware Corporation. All rights reserved. The Compuware products and services listed within this release are trademarks or registered trademarks of Compuware Corporation.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Compuware Corporation via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies24.6.2019 23:30:00 CEST | Pressemelding
LYON, France and CAMBRIDGE, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (ERYTECH) (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells (RBCs), announced today that it has entered into an agreement with SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments in multiple therapeutic areas, to advance novel RBC-based therapeutics for immune modulation . Under the terms of the agreement, ERYTECH has granted to SQZ an exclusive worldwide license to develop antigen-specific immune modulating therapies employing RBC-based approaches. Combining SQZ’s proprietary and versatile cell engineering platform, Cell Squeeze®, with ERYTECH’s intellectual property related to RBC-based therapeutics is intended to allow for the rapid development of a broad pipeline of novel immunomodulatory products addressing multiple indications. ERYTECH is eligible to rec
Forterra Announces Leadership Appointments24.6.2019 22:24:00 CEST | Pressemelding
Construction Materials Veteran Karl H. Watson, Jr. Named Chief Executive Officer Forterra Board Member John McPherson Appointed Lead Director and Vice Chairman of the Board Company Reaffirms Full Year 2019 Outlook IRVING, Texas, June 24, 2019 (GLOBE NEWSWIRE) -- Forterra, Inc. (“Forterra” or the “Company”) (NASDAQ:FRTA), a leading manufacturer of water and drainage infrastructure pipe and products in the United States and Eastern Canada, today announced that Karl H. Watson, Jr. has been appointed Chief Executive Officer and a member of the Forterra Board of Directors. Mr. Watson succeeds Jeff Bradley, who has stepped down as CEO and a director to pursue other opportunities. Mr. Watson brings over 30 years of global experience in the construction materials industry and a track record of effectively leading through numerous business cycles and improving financial and operational results. He most recently served as Executive Vice President and Chief Operating Officer at Summit Materials,
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman24.6.2019 17:35:00 CEST | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it has appointed Patrick J. Balthrop, Sr. as Chairman of its board of directors. The current Chairman, Mr. Richard A. Sandberg, will remain a member of the board. “On behalf of the Company and the board of directors I would like to thank our former Chairman, Richard Sandberg, for his service,” said Dr. Peter Wrighton-Smith, CEO of Oxford Immunotec. “In the decade that he served as Chairman, the Company has undergone a profound transformation, and Mr. Sandberg’s guidance and leadership has made an extraordinary contribution to Oxford Immunotec’s success. We look forward to continuing to benefit from his skills and his knowledge of the Company with his ongoing service as a Non-Executive Director.” “We are very pleased to have Mr. Balthrop assume the role of Chairman,” continued Dr. Wrigh
Woodbridge by Robert Mondavi Announces New Transformative Brand Positioning24.6.2019 15:50:00 CEST | Pressemelding
“From One For All” National Campaign Brings Brand’s Pioneering Spirit to the Forefront of Story and Marks a Number of Brand Firsts LODI, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Woodbridge by Robert Mondavi, the number-three wine brand in the United States* with 40 years of history dedicated to raising the standard for everyday wines in America and globally, announces a new milestone with the launch of its new national brand campaign. The “From One For All” campaign celebrates Woodbridge founder Robert Mondavi’s pivotal role in democratizing wine. It is supported by a 360-degree integrated marketing plan backed by the largest investment in the brand’s history. For the first time, Woodbridge by Robert Mondavi tells the winery’s powerful founding story and industry-changing vision through the lens of its iconic founder Robert Mondavi in the new “From One For All” marketing campaign. Celebrated for his achievements helping to establish California’s reputation for fine winemaking on a glo
Sanan IC Expands Wafer Foundry Portfolio for Power Electronics with 150mm GaN-on-Silicon Process24.6.2019 15:00:00 CEST | Pressemelding
SUNNYVALE, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- SANAN INTEGRATED CIRCUIT CO., LTD. (Sanan IC), a pure-play wafer foundry with its advanced compound semiconductor technology platform, today announced the commercial release of its 150mm gallium nitride (GaN) on silicon wafer foundry services intended for the latest high voltage AC/DC and DC/AC power electronics applications in the global market. Sanan IC’s new G06P111 is a 650V enhanced-mode high-electron-mobility transistor (E-HEMT) GaN process which adds to the company’s power electronics wafer foundry portfolio of wide bandgap (WBG) compound semiconductors that includes 100mm and 150mm silicon carbide (SiC) for high voltage Schottky Barrier Diodes (SBD). Leveraging years of high volume GaN manufacturing experience by Sanan Optoelectronics Inc., its parent company, for the LED market, Sanan IC is able to complement its foundry services with in-house MOCVD growth capabilities of high voltage, low leakage GaN-on-silicon epitaxial wa
Nasdaq Promotes Tal Cohen to Executive Vice President, North American Market Services24.6.2019 14:30:00 CEST | Pressemelding
Tom Wittman to become Executive Advisor and to retire from Nasdaq at year-end NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Nasdaq, Inc. today announced it has named Tal Cohen as Executive Vice President, North American Market Services, effective July 1. In this role, Cohen will be responsible for driving the strategy and success of our trading businesses across cash equities, commodities, derivatives, and trade management services in Nasdaq’s U.S. and Canadian markets. In his role, in addition to directing the strategy of the business, Cohen will oversee Nasdaq’s North American trading products across their lifecycle and will manage client relationships and market operations. He will report to Adena Friedman, President and CEO, Nasdaq. Cohen joined Nasdaq in April 2016 as Senior Vice President of North American Equities following the acquisition of Chi-X Canada, where he had served as CEO of Chi-X Global Holdings for six years. Prior to Chi-X, Cohen held senior positions at Instinet, Am